Abstract
Rationale
Obsessive-compulsive disorder (OCD) is characterized by repetitive behaviors exacerbated by stress. Many OCD patients do not respond to available pharmacotherapies, but neurosurgical ablation of the anterior cingulate cortex (ACC) can provide symptomatic relief. Although the ACC receives noradrenergic innervation and expresses adrenergic receptors (ARs), the involvement of norepinephrine (NE) in OCD has not been investigated.
Objective
To determine the effects of genetic or pharmacological disruption of NE neurotransmission on marble burying (MB) and nestlet shredding (NS), two animal models of OCD.
Methods
We assessed NE-deficient (Dbh −/−) mice and NE-competent (Dbh +/−) controls in MB and NS tasks. We also measured the effects of anti-adrenergic drugs on NS and MB in control mice and the effects of pharmacological restoration of central NE in Dbh −/− mice. Finally, we compared c-fos induction in the locus coeruleus (LC) and ACC of Dbh −/− and control mice following both tasks.
Results
Dbh −/− mice virtually lacked MB and NS behaviors seen in control mice but did not differ in the elevated zero maze (EZM) model of general anxiety-like behavior. Pharmacological restoration of central NE synthesis in Dbh −/− mice completely rescued NS behavior, while NS and MB were suppressed in control mice by anti-adrenergic drugs. Expression of c-fos in the ACC was attenuated in Dbh −/− mice after MB and NS.
Conclusion
These findings support a role for NE transmission to the ACC in the expression of stress-induced compulsive behaviors and suggest further evaluation of anti-adrenergic drugs for OCD is warranted.
Similar content being viewed by others
References
Abraham PA, Xing G, Zhang L, Eric ZY, Post R, Gamble EH, Li H (2008) β1-and β2-adrenoceptor induced synaptic facilitation in rat basolateral amygdala. Brain Res 1209:65–73
Adams TG, Kelmendi B, Brake CA, Gruner P, Badour CL, Pittenger C (2018) The role of stress in the pathogenesis and maintenance of obsessive-compulsive disorder. Chronic Stress 2:2470547018758043
Ahmari SE, Dougherty DD (2015) Dissecting OCD circuits: from animal models to targeted treatments. Depress Anxiety 32:550–562
Alarcon RD, Libb J, Boll T (1994) Neuropsychological testing in obsessive-compulsive disorder: a clinical review. J Neuropsychiatry Clin Neurosci 6:217–217
Angoa-Pérez M, Kane MJ, Briggs DI, Sykes CE, Shah MM, Francescutti DM, Rosenberg DR, Thomas DM, Kuhn DM (2012) Genetic depletion of brain 5HT reveals a common molecular pathway mediating compulsivity and impulsivity. J Neurochem 121:974–984
Angoa-Pérez M, Kane MJ, Briggs DI, Francescutti DM, Kuhn DM (2013) Marble burying and nestlet shredding as tests of repetitive, compulsive-like behaviors in mice. J Vis Exp (82):50978. https://doi.org/10.3791/50978
Arnsten A, Cai JX, Goldman-Rakic PS (1988) The alpha-2 adrenergic agonist guanfacine improves memory in aged monkeys without sedative or hypotensive side effects: evidence for alpha-2 receptor subtypes. J Neurosci 8:4287–4298
Aston-Jones G, Waterhouse B (2016) Locus coeruleus: from global projection system to adaptive regulation of behavior. Brain Res 1645:75–78
Aston-Jones G, Rajkowski J, Cohen J (1999) Role of locus coeruleus in attention and behavioral flexibility. Biol Psychiatry 46:1309–1320
Aston-Jones G, Iba M, Clayton E, Rajkowski J, Cohen J (2007) The locus coeruleus and regulation of behavioral flexibility and attention: clinical implications. Brain Norepinephrine: Neurobiol Therapeut 196–235
Benkelfat C, Mefford IN, Masters CF, Nordahl TE, King AC, Cohen RM, Murphy DL (1991) Plasma catecholamines and their metabolites in obsessive-compulsive disorder. Psychiatry Res 37:321–331
Berridge C, Arnsten A, Foote S (1993) Noradrenergic modulation of cognitive function: clinical implications of anatomical, electrophysiological and behavioural studies in animal models. Psychol Med 23:557–564
Billett E, Richter M, Sam F, Swinson R, Dai X-Y, King N, Badri F, Sasaki T, Buchanan J, Kennedy J (1998) Investigation of dopamine system genes in obsessive–compulsive disorder. Psychiatr Genet
Brady LS (1994) Stress, antidepressant drugs, and the locus coeruleus. Brain Res Bull 35:545–556
Brambilla F, Bellodi L, Perna G, Arancio C, Bertani A, Perini G, Carraro C, Gava F (1997) Noradrenergic receptor sensitivity in obsessive compulsive disorder: II. Cortisol response to acute clonidine administration. Psychiatry Res 69:163–168
Brennan BP, Rauch SL, Jensen JE, Pope HG Jr (2013) A critical review of magnetic resonance spectroscopy studies of obsessive-compulsive disorder. Biol Psychiatry 73:24–31
Brennan BP, Tkachenko O, Schwab ZJ, Juelich RJ, Ryan EM, Athey AJ, Pope HG, Jenike MA, Baker JT, Killgore WD (2015) An examination of rostral anterior cingulate cortex function and neurochemistry in obsessive–compulsive disorder. Neuropsychopharmacology 40:1866
Broese M, Riemann D, Hein L, Nissen C (2012) α-Adrenergic receptor function, arousal and sleep: mechanisms and therapeutic implications. Pharmacopsychiatry 45:209–216
Brown LT, Mikell CB, Youngerman BE, Zhang Y, McKhann GM, Sheth SA (2016) Dorsal anterior cingulotomy and anterior capsulotomy for severe, refractory obsessive-compulsive disorder: a systematic review of observational studies. J Neurosurg 124:77–89
Chappell PB, Riddle MA, Scahill L, Lynch KA, Schultz R, Arnsten A, Leckman JF, Cohen DJ (1995) Guanfacine treatment of comorbid attention-deficit hyperactivity disorder and Tourette’s syndrome: preliminary clinical experience. J Am Acad Child Adolesc Psychiatry 34:1140–1146
Chen Y-W, Das M, Oyarzabal EA, Cheng Q, Plummer NW, Smith KG, Jones GK, Malawsky D, Yakel JL, Shih Y-YI, Jensen P (2019) Genetic identification of a population of noradrenergic neurons implicated in attenuation of stress-related responses. Mol Psychiatry 24:710–725. https://doi.org/10.1038/s41380-018-0245-8
Cocchi L, Harrison BJ, Pujol J, Harding IH, Fornito A, Pantelis C, Yücel M (2012) Functional alterations of large-scale brain networks related to cognitive control in obsessive-compulsive disorder. Hum Brain Mapp 33:1089–1106
Cohen R, Kaplan R, Moser D, Jenkins M, Wilkinson H (1999a) Impairments of attention after cingulotomy. Neurology 53:819–819
Cohen RA, Kaplan RF, Zuffante P, Moser DJ, Jenkins MA, Salloway S, Wilkinson H (1999b) Alteration of intention and self-initiated action associated with bilateral anterior cingulotomy. J Neuropsychiatry Clin Neurosci 11:444–453
Colombo G, Maccioni P, Vargiolu D, Loi B, Lobina C, Zaru A, Carai MA, Gessa GL (2014) The dopamine β-hydroxylase inhibitor, nepicastat, reduces different alcohol-related behaviors in rats. Alcohol Clin Exp Res 26:2345–2353
Cosgrove GR, Rauch SL (2003) Stereotactic cingulotomy. Neurosurg Clin N Am 14:225–235
Crino PB, Morrison JH, Hof PR (1993) Monoaminergic innervation of cingulate cortex. In: Neurobiology of cingulate cortex and limbic thalamus. Springer, pp 285–310
Cummings DD, Singer HS, Krieger M, Miller TL, Mahone EM (2002) Neuropsychiatric effects of guanfacine in children with mild tourette syndrome: a pilot study. Clin Neuropharmacol 25:325–332
Czyrak A, Czepiel K, Maćkowiak M, Chocyk A, Wędzony K (2003) Serotonin 5-HT1A receptors might control the output of cortical glutamatergic neurons in rat cingulate cortex. Brain Res 989:42–51
De Geus F, Denys DA, Sitskoorn MM, Westenberg HG (2007) Attention and cognition in patients with obsessive–compulsive disorder. Psychiatry Clin Neurosci 61:45–53
De La Garza IIR, Bubar MJ, Carbone CL, Moeller FG, Newton TF, Anastasio NC, Harper TA, Ware DL, Fuller MA, Holstein GJJPiN, Psychiatry B (2015) Evaluation of the dopamine β-hydroxylase (DβH) inhibitor nepicastat in participants who meet criteria for cocaine use disorder. Prog Neuro-Psychopharmacol Biol Psychiatry 59:40–48
De Ridder D, Leong SL, Manning P, Vanneste S, Glue P (2017) Anterior cingulate implant for obsessive-compulsive disorder. World Neurosurg 97:754. e757–754. e716
Dominguez RA (1992) Serotonergic antidepressants and their efficacy in obsessive compulsive disorder. J Clin Psychiatry
Durcan MJ, Lister RG, Linnoila M (1989) Behavioral effects of alpha 2 adrenoceptor antagonists and their interactions with ethanol in tests of locomotion, exploration and anxiety in mice. Psychopharmacology 97:189–193
Feenstra MG, Klompmakers A, Figee M, Fluitman S, Vulink N, Westenberg HG, Denys D (2016) Prazosin addition to fluvoxamine: a preclinical study and open clinical trial in OCD. Eur Neuropsychopharmacol 26:310–319
Fineberg N, Chamberlain S, Hollander E, Boulougouris V, Robbins T (2011) Translational approaches to obsessive-compulsive disorder: from animal models to clinical treatment. Br J Pharmacol 164:1044–1061
Fitzgerald KD, Welsh RC, Gehring WJ, Abelson JL, Himle JA, Liberzon I, Taylor SF (2005) Error-related hyperactivity of the anterior cingulate cortex in obsessive-compulsive disorder. Biol Psychiatry 57:287–294
Flavin SA, Winder DG (2013) Noradrenergic control of the bed nucleus of the stria terminalis in stress and reward. Neuropharmacology 70:324–330
Fodstad H, Strandman E, Karlsson B, West K (1982) Treatment of chronic obsessive compulsive states with stereotactic anterior capsulotomy or cingulotomy. Acta Neurochir 62:1–23
Gehring WJ, Himle J, Nisenson LG (2000) Action-monitoring dysfunction in obsessive-compulsive disorder. Psychol Sci 11:1–6
Gompf HS, Mathai C, Fuller PM, Wood DA, Pedersen NP, Saper CB, Lu J (2010) Locus ceruleus and anterior cingulate cortex sustain wakefulness in a novel environment. J Neurosci 30:14543–14551
Goodman WK, McDougle CJ, Price LH, Riddle MA, Pauls D, Leckman J. (1990) Beyond the serotonin hypothesis: a role for dopamine in some forms of obsessive compulsive disorder? J Clin Psychiatry
Gorman AL, Dunn AJJPB, Behavior (1993) β-Adrenergic receptors are involved in stress-related behavioral changes. Pharmacol Biochem Behav 45:1–7
Graybiel AM, Rauch SL (2000) Toward a neurobiology of obsessive-compulsive disorder. Neuron 28:343–347
Hajós M, Gartside SE, Varga V, Sharp T (2003) In vivo inhibition of neuronal activity in the rat ventromedial prefrontal cortex by midbrain-raphe nuclei: role of 5-HT1A receptors. Neuropharmacology 45:72–81
Hollander E, DeCaria C, Nitescu A, Cooper T, Stover B, Gully R, Klein DF, Liebowitz MR (1991) Noradrenergic function in obsessive-compulsive disorder: behavioral and neuroendocrine responses to clonidine and comparison to healthy controls. Psychiatry Res 37:161–177
Itoi K, Sugimoto N (2010) The brainstem noradrenergic systems in stress, anxiety and depression. J Neuroendocrinol 22:355–361
Janer KW, Pardo JV (1991) Deficits in selective attention following bilateral anterior cingulotomy. J Cogn Neurosci 3:231–241
Ji M-H, Jia M, Zhang M-Q, Liu W-X, Xie Z-C, Wang Z-Y, Yang J-J (2014) Dexmedetomidine alleviates anxiety-like behaviors and cognitive impairments in a rat model of post-traumatic stress disorder. Progress Neuro-Psychopharmacol Biol Psychiatry 54:284–288
Jimenez-Gomez C, Osentoski A, Woods JH (2011) Pharmacological evaluation of the adequacy of marble burying as an animal model of compulsion and/or anxiety. Behav Pharmacol 22:711
Joel D (2006) Current animal models of obsessive compulsive disorder: a critical review. Prog Neuro-Psychopharmacol Biol Psychiatry 30:374–388
Jung HH, Kim C-H, Chang JH, Park YG, Chung SS, Chang JW (2006) Bilateral anterior cingulotomy for refractory obsessive-compulsive disorder: long-term follow-up results. Stereotact Funct Neurosurg 84:184–189
Kalanthroff E, Linkovski O, Weinbach N, Pascucci O, Anholt GE, Simpson HB (2016) What underlies the effect of sleep disruption? The role of alertness in obsessive-compulsive disorder (OCD). J Behav Ther Experiment Psychiatry 55:212–213
Kane MJ, Angoa-Peréz M, Briggs DI, Sykes CE, Francescutti DM, Rosenberg DR, Kuhn DM (2012) Mice genetically depleted of brain serotonin display social impairments, communication deficits and repetitive behaviors: possible relevance to autism. PLoS One 7:e48975
Karayiorgou M, Sobin C, Blundell ML, Galke BL, Malinova L, Goldberg P, Ott J, Gogos JA (1999) Family-based association studies support a sexually dimorphic effect of COMT and MAOA on genetic susceptibility to obsessive-compulsive disorder. Biol Psychiatry 45:1178–1189
Kauppila T, Tanila H, Carlson S, Taira T (1991) Effects of atipamezole, a novel α2-adrenoceptor antagonist, in open-field, plus-maze, two compartment exploratory, and forced swimming tests in the rat. Eur J Pharmacol 205:177–182
Kedia S, Chattarji S (2014) Marble burying as a test of the delayed anxiogenic effects of acute immobilisation stress in mice. J Neurosci Methods 233:150–154
Kim CH, Chang J, Koo MS, Kim J, Suh H, Park I, Lee H (2003) Anterior cingulotomy for refractory obsessive–compulsive disorder. Acta Psychiatr Scand 107:283–290
Kim M-A, Lee HS, Lee BY, Waterhouse BD (2004) Reciprocal connections between subdivisions of the dorsal raphe and the nuclear core of the locus coeruleus in the rat. Brain Res 1026:56–67
Knesevich JW (1982) Successful treatment of obsessive-compulsive disorder with clonidine hydrochloride. Am J Psychiatry
Langen M, Durston S, Kas MJ, van Engeland H, Staal WG (2011) The neurobiology of repetitive behavior:… and men. Neurosci Biobehav Rev 35:356–365
Le A, Funk D, Juzytsch W, Coen K, Navarre BM, Cifani C, Shaham Y (2011) Effect of prazosin and guanfacine on stress-induced reinstatement of alcohol and food seeking in rats. Psychopharmacology 218:89–99
Lederman RJ (1999) Medical treatment of performance anxiety. Anxiety
Lee H-M, Kim Y. (2016). Drug repurposing is a new opportunity for developing drugs against neuropsychiatric disorders. Schizophrenia Res Treatment 2016
Li X, Morrow D, Witkin JM (2006) Decreases in nestlet shredding of mice by serotonin uptake inhibitors: comparison with marble burying. Life Sci 78:1933–1939
Lin H, Katsovich L, Ghebremichael M, Findley DB, Grantz H, Lombroso PJ, King RA, Zhang H, Leckman JF (2007) Psychosocial stress predicts future symptom severities in children and adolescents with Tourette syndrome and/or obsessive-compulsive disorder. J Child Psychol Psychiatry 48:157–166
Lipsedge M Prothero W (1987) Clonidine and clomipramine in obsessive-compulsive disorder. Am J Psychiatry
Loughlin SE, Foote SL, Fallon JH (1982) Locus coeruleus projections to cortex: topography, morphology and collateralization. Brain Res Bull 9:287–294
Luttinger D, Ferrari R, Perrone M, Haubrich D (1985) Pharmacological analysis of alpha-2 adrenergic mechanisms in nociception and ataxia. J Pharmacol Exp Ther 232:883–889
Mantsch JR, Weyer A, Vranjkovic O, Beyer CE, Baker DA, Caretta H (2010) Involvement of noradrenergic neurotransmission in the stress-but not cocaine-induced reinstatement of extinguished cocaine-induced conditioned place preference in mice: role for β-2 adrenergic receptors. Neuropsychopharmacology 35:2165
Margulies DS, Kelly AC, Uddin LQ, Biswal BB, Castellanos FX, Milham MP (2007) Mapping the functional connectivity of anterior cingulate cortex. Neuroimage 37:579–588
Marino MD, Bourdélat-Parks BN, Liles LC, Weinshenker D (2005) Genetic reduction of noradrenergic function alters social memory and reduces aggression in mice. Behav Brain Res 161:197–203
Marzo A, Totah NK, Neves RM, Logothetis NK, Eschenko O (2014) Unilateral electrical stimulation of rat locus coeruleus elicits bilateral response of norepinephrine neurons and sustained activation of medial prefrontal cortex. J Neurophysiol 111:2570–2588
Mavissakalian M, Michelson L. (1983). Tricyclic antidepressants in obsessive-compulsive disorder: antiobsessional or antidepressant agents? J Nervous Mental Dis
Mavrogiorgou P, Juckel G, Frodl T, Gallinat J, Hauke W, Zaudig M, Dammann G, Möller H-J, Hegerl U (2002) P300 subcomponents in obsessive-compulsive disorder. J Psychiatr Res 36:399–406
McCall JG, Al-Hasani R, Siuda ER, Hong DY, Norris AJ, Ford CP, Bruchas MR (2015) CRH engagement of the locus coeruleus noradrenergic system mediates stress-induced anxiety. Neuron 87:605–620
McCall JG, Siuda ER, Bhatti DL, Lawson LA, McElligott ZA, Stuber GD, Bruchas MR (2017) Locus coeruleus to basolateral amygdala noradrenergic projections promote anxiety-like behavior. Elife 6:e18247
McGovern RA, Sheth SA (2017) Role of the dorsal anterior cingulate cortex in obsessive-compulsive disorder: converging evidence from cognitive neuroscience and psychiatric neurosurgery. J Neurosurg 126:132–147
Micallef J, Blin O (2001) Neurobiology and clinical pharmacology of obsessive-compulsive disorder. Clin Neuropharmacol 24:191–207
Millan MJ, Lejeune F, Gobert A, Brocco M, Auclair A, Bosc C, Rivet J-M, Lacoste J-M, Cordi A, Dekeyne A (2000) S18616, a highly potent spiroimidazoline agonist at α2-adrenoceptors: II. Influence on monoaminergic transmission, motor function, and anxiety in comparison with dexmedetomidine and clonidine. J Pharmacol Exp Therapeut 295:1206–1222
Mitchell HA, Ahern TH, Liles LC, Javors MA, Weinshenker D (2006) The effects of norepinephrine transporter inactivation on locomotor activity in mice. Biol Psychiatry 60:1046–1052
Mitchell HA, Bogenpohl JW, Liles LC, Epstein MP, Bozyczko-Coyne D, Williams M, Weinshenker D (2008) Behavioral responses of dopamine β-hydroxylase knockout mice to modafinil suggest a dual noradrenergic–dopaminergic mechanism of action. Pharmacol Biochem Behav 91:217–222
Murchison CF, Zhang X-Y, Zhang W-P, Ouyang M, Lee A, Thomas SA (2004) A distinct role for norepinephrine in memory retrieval. Cell 117:131–143
O'Leary OF, Bechtholt AJ, Crowley JJ, Valentino RJ, Lucki I (2007) The role of noradrenergic tone in the dorsal raphe nucleus of the mouse in the acute behavioral effects of antidepressant drugs. Eur Neuropsychopharmacol 17:215–226
Pasquier DA, Kemper TL, Forbes WB, Morgane PJ (1977) Dorsal raphe, substantia nigra and locus coeruleus: interconnections with each other and the neostriatum. Brain Res Bull 2:323–339
Pauls DL, Abramovitch A, Rauch SL, Geller DA (2014) Obsessive–compulsive disorder: an integrative genetic and neurobiological perspective. Nat Rev Neurosci 15:410–424
Pigott TA, L'Heureux F, Dubbert B, Bernstein S, Murphy DL (1994) Obsessive compulsive disorder: comorbid conditions. J Clin Psychiatry 55:15–27 discussion 28-32
Pittenger C, Krystal JH, Coric V (2006) Glutamate-modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive-compulsive disorder. NeuroRx 3:69–81
Pittenger C, Bloch MH, Williams K (2011) Glutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatment. Pharmacol Therapeut 132:314–332
Pizarro M, Fontenelle LF, Paravidino DC, Yücel M, Miguel EC, de Menezes GB (2014) An updated review of antidepressants with marked serotonergic effects in obsessive–compulsive disorder. Expert Opin Pharmacother 15:1391–1401
Pooley E, Fineberg N, Harrison P (2007) The met 158 allele of catechol-O-methyltransferase (COMT) is associated with obsessive-compulsive disorder in men: case–control study and meta-analysis. Mol Psychiatry 12:556
Porter-Stransky KA, Centanni SW, Karne SL, Odil LM, Fekir S, Wong JC, Jerome C, Mitchell HA, Escayg A, Pedersen NP (2019) Noradrenergic transmission at alpha1-adrenergic receptors in the ventral periaqueductal gray modulates arousal. Biol Psychiatry 85:237–247
Posey DJ, McDougle CJ (2007) Guanfacine and guanfacine extended release: treatment for ADHD and related disorders. CNS Drug Rev 13:465–474
Pudovkina OL, Cremers TI, Westerink BH (2002) The interaction between the locus coeruleus and dorsal raphe nucleus studied with dual-probe microdialysis. Eur J Pharmacol 445:37–42
Qu LL, Guo NN, Li BM (2008) β1-and β2-Adrenoceptors in basolateral nucleus of amygdala and their roles in consolidation of fear memory in rats. Hippocampus 18:1131–1139
Rainbow TC, Parsons B, Wolfe BB (1984) Quantitative autoradiography of beta 1-and beta 2-adrenergic receptors in rat brain. Proc Natl Acad Sci 81:1585–1589
Rasmussen DD, Kincaid CL, Froehlich JC. (2016). Prazosin prevents increased anxiety behavior that occurs in response to stress during alcohol deprivations. Alcohol and Alcoholism 1–7
Riffkin J, Yücel M, Maruff P, Wood SJ, Soulsby B, Olver J, Kyrios M, Velakoulis D, Pantelis C (2005) A manual and automated MRI study of anterior cingulate and orbito-frontal cortices, and caudate nucleus in obsessive-compulsive disorder: comparison with healthy controls and patients with schizophrenia. Psychiatry Res Neuroimaging 138:99–113
Rinaman L (2010) Hindbrain noradrenergic A2 neurons: diverse roles in autonomic, endocrine, cognitive, and behavioral functions. Am J Phys Regul Integr Comp Phys 300:R222–R235
Robertson SD, Plummer NW, De Marchena J, Jensen P (2013) Developmental origins of central norepinephrine neuron diversity. Nat Neurosci 16:1016
Robertson SD, Plummer NW, Jensen P (2016) Uncovering diversity in the development of central noradrenergic neurons and their efferents. Brain Res 1641:234–244
Rommelfanger K, Edwards G, Freeman K, Liles L, Miller G, Weinshenker D (2007) Norepinephrine loss produces more profound motor deficits than MPTP treatment in mice. Proc Natl Acad Sci 104:13804–13809
Roozendaal B, Hahn EL, Nathan SV, Dominique J-F, McGaugh JL (2004) Glucocorticoid effects on memory retrieval require concurrent noradrenergic activity in the hippocampus and basolateral amygdala. J Neurosci 24:8161–8169
Roozendaal B, Okuda S, Van der Zee EA, McGaugh JLJ (2006) Glucocorticoid enhancement of memory requires arousal-induced noradrenergic activation in the basolateral amygdala. Proc Natl Acad Sci 103:6741–6746
Rosso G, Albert U, Asinari GF, Bogetto F, Maina G (2012) Stressful life events and obsessive–compulsive disorder: clinical features and symptom dimensions. Psychiatry Res 197:259–264
Rudoy C, Van Bockstaele E (2007) Betaxolol, a selective β1-adrenergic receptor antagonist, diminishes anxiety-like behavior during early withdrawal from chronic cocaine administration in rats. Progress Neuro-Psychopharmacol Biol Psychiatry 31:1119–1129
Sallee FR, Eaton K (2010) Guanfacine extended-release for attention-deficit/hyperactivity disorder (ADHD). Expert Opin Pharmacother 11:2549–2556
Sallee FR, Mcgough J, Wigal T, Donahue J, Lyne A, Biederman J (2009) Guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder: a placebo-controlled trial. J Am Acad Child Adolesc Psychiatry 112:155–165
Sara SJ (2009) The locus coeruleus and noradrenergic modulation of cognition. Nat Rev Neurosci 10:211
Schank JR, Liles LC, Weinshenker D (2008) Norepinephrine signaling through β-adrenergic receptors is critical for expression of cocaine-induced anxiety. Biol Psychiatry 63:1007–1012
Schindler KM, Richter M, Kennedy JL, Pato MT, Pato CN (2000) Association between homozygosity at the COMT gene locus and obsessive compulsive disorder. Am J Med Genet 96:721–724
Scholtysik G (1980) Pharmacology of guanfacine. Br J Clin Pharmacol 10:21S–24S
Schroeder JP, Epps SA, Grice TW, Weinshenker D (2013) The selective dopamine β-hydroxylase inhibitor nepicastat attenuates multiple aspects of cocaine-seeking behavior. Neuropsychopharmacology 38:1032
Segal M (1979) Serotonergic innervation of the locus coeruleus from the dorsal raphe and its action on responses to noxious stimuli. J Physiol 286:401–415
Shepherd JK, Grewal SS, Fletcher A, Bill DJ, Dourish CT (1994) Behavioural and pharmacological characterisation of the elevated “zero-maze” as an animal model of anxiety. Psychopharmacology 116:56–64
Siever LJ, Insel TR, Jimerson DC, Lake CR, Uhde TW, Aloi J, Murphy DL (1983) Growth hormone response to clonidine in obsessive-compulsive patients. Br J Psychiatry 142:184–187
Skelly MJ, Weiner JL (2014) Chronic treatment with prazosin or duloxetine lessens concurrent anxiety-like behavior and alcohol intake: evidence of disrupted noradrenergic signaling in anxiety-related alcohol use. Brain Behav 4:468–483
Spitznagel MB, Suhr JA (2002) Executive function deficits associated with symptoms of schizotypy and obsessive–compulsive disorder. Psychiatry Res 110:151–163
Steenen SA, van Wijk AJ, Van Der Heijden GJ, van Westrhenen R, de Lange J, de Jongh A (2016) Propranolol for the treatment of anxiety disorders: systematic review and meta-analysis. J Psychopharmacol 30:128–139
Stein DJ (2000) Neurobiology of the obsessive–compulsive spectrum disorders. Biol Psychiatry 47:296–304
Stemmelin J, Cohen C, Terranova J-P, Lopez-Grancha M, Pichat P, Bergis O, Decobert M, Santucci V, Françon D, Alonso R (2008) Stimulation of the β 3-adrenoceptor as a novel treatment strategy for anxiety and depressive disorders. Neuropsychopharmacology 33:574
Stevens FL, Hurley RA, Taber KH (2011) Anterior cingulate cortex: unique role in cognition and emotion. J Neuropsychiatry Clin Neurosci 23:121–125
Stone E, Zhang Y, Rosengarten H, Yeretsian J, Quartermain D (1999) Brain alpha 1-adrenergic neurotransmission is necessary for behavioral activation to environmental change in mice. Neuroscience 94:1245–1252
Stone EA, Lin Y, Rosengarten H, Kramer HK, Quartermain D (2003) Emerging evidence for a central epinephrine-innervated α 1-adrenergic system that regulates behavioral activation and is impaired in depression. Neuropsychopharmacology 28:1387
Stone EA, Lin Y, Ahsan R, Quartermain D (2004) Gross mapping of α1-adrenoceptors that regulate behavioral activation in the mouse brain. Behav Brain Res 152:167–175
Stone EA, Lin Y, Ahsan MR, Quartermain D (2005) α 1-Adrenergic and α 2-adrenergic balance in the dorsal pons and gross behavioral activity of mice in a novel environment. Psychopharmacology 183:127
Stone EA, Yan L, Ahsan MR, Lehmann ML, Yeretsian J, Quartermain D (2006) Role of CNS α1-adrenoceptor activity in central fos responses to novelty. Synapse 59:299–307
Sugimoto Y, Tagawa N, Kobayashi Y, Hotta Y, Yamada J (2007) Effects of the serotonin and noradrenaline reuptake inhibitor (SNRI) milnacipran on marble burying behavior in mice. Biol Pharm Bull 30:2399–2401
Szabo ST, Blier P (2001) Functional and pharmacological characterization of the modulatory role of serotonin on the firing activity of locus coeruleus norepinephrine neurons. Brain Res 922:9–20
Tanaka E, North RA (1993) Actions of 5-hydroxytryptamine on neurons of the rat cingulate cortex. J Neurophysiol 69:1749–1757
Taormina SP, Galloway MP, Rosenberg DR (2016) Treatment efficacy of combined sertraline and guanfacine in comorbid OCD and ADHD: two case studies. J Dev Behav Pediatr 37:491
Thomas SA, Matsumoto AM, Palmiter RD (1995) Noradrenaline is essential for mouse fetal development. Nature 374:643
Thomas SA, Marck BT, Palmiter RD, Matsumoto AM (1998) Restoration of norepinephrine and reversal of phenotypes in mice lacking dopamine β-hydroxylase. J Neurochem 70:2468–2476
Thomas A, Burant A, Bui N, Graham D, Yuva-Paylor LA, Paylor R (2009) Marble burying reflects a repetitive and perseverative behavior more than novelty-induced anxiety. Psychopharmacology 204:361–373
Tillage RP, Sciolino NR, Plummer NW, Lustberg D, Liles LC, Hsiang M, Powell JM, Smith KG, Jensen P, Weinshenker D (2020) Elimination of galanin synthesis in noradrenergic neurons reduces galanin in select brain areas and promotes active coping behaviors. Brain Struct Function 1–19
Ting JT, Feng G (2011) Neurobiology of obsessive–compulsive disorder: insights into neural circuitry dysfunction through mouse genetics. Curr Opin Neurobiol 21:842–848
Uematsu A, Tan BZ, Johansen JP (2015) Projection specificity in heterogeneous locus coeruleus cell populations: implications for learning and memory. Learn Mem 22:444–451
Valentino RJ, Foote SL, Page ME (1993) The locus coeruleus as a site for integrating corticotropin-releasing factor and noradrenergic mediation of stress responses a. Ann N Y Acad Sci 697:173–188
van Balkom AJ, van Oppen P, Vermeulen AW, van Dyck R, Nauta MC, Vorst HC (1994) A meta-analysis on the treatment of obsessive compulsive disorder: a comparison of antidepressants, behavior, and cognitive therapy. Clin Psychol Rev 14:359–381
Van Der Laan JW, Van Veenendaal W, Voorthuis P, Weick G, Hillen FC (1985) The effects of centrally acting adrenergic agonists on temperature and on explorative and motor behaviour. Relation with effects on quasi-morphine withdrawal behaviour. Eur J Pharmacol 107:367–373
Van Laere K, Nuttin B, Gabriels L, Dupont P, Rasmussen S, Greenberg BD, Cosyns P (2006) Metabolic imaging of anterior capsular stimulation in refractory obsessive-compulsive disorder: a key role for the subgenual anterior cingulate and ventral striatum. J Nucl Med 47:740–747
Vankov A, Hervé-Minvielle A, Sara SJ (1995) Response to novelty and its rapid habituation in locus coeruleus neurons of the freely exploring rat. Eur J Neurosci 7:1180–1187
Weinshenker D, Miller NS, Blizinsky K, Laughlin ML, Palmiter RD (2002) Mice with chronic norepinephrine deficiency resemble amphetamine-sensitized animals. Proc Natl Acad Sci 99:13873–13877
Witkin JM (2008) Animal models of obsessive-compulsive disorder. Curr Protocols Neurosci 45:9.30. 31–39.30. 39
Wolmarans DW, Stein DJ, Harvey BH (2016) Of mice and marbles: novel perspectives on burying behavior as a screening test for psychiatric illness. Cogn Affect Behav Neurosci 16:551–560
Young R, Batkai S, Dukat M, Glennon RA (2006) TDIQ (5, 6, 7, 8-tetrahydro-1, 3-dioxolo [4, 5-g] isoquinoline) exhibits anxiolytic-like activity in a marble-burying assay in mice. Pharmacol Biochem Behav 84:62–73
Yücel M, Wood SJ, Fornito A, Riffkin J, Velakoulis D, Pantelis C (2003) Anterior cingulate dysfunction: implications for psychiatric disorders? J Psychiatry Neurosci 28:350
Zheng J, Luo F, Guo N-n, Cheng Z-y, B-m L (2015) β1-and β2-adrenoceptors in hippocampal CA3 region are required for long-term memory consolidation in rats. Brain Res 1627:109–118
Zhou H-C, Sun Y-Y, Cai W, He X-T, Yi F, Li B-M, Zhang X-H (2013) Activation of β2-adrenoceptor enhances synaptic potentiation and behavioral memory via cAMP-PKA signaling in the medial prefrontal cortex of rats. Learn Mem 20:274–284
Zohar J, Chopra M, Sasson Y, Amiaz R, Amital D (2000) Obsessive compulsive disorder: serotonin and beyond. World J Biol Psychiatry 1:92–100
Acknowledgments
We thank Lundbeck for providing the DOPS, Synosia Therapeutics for providing the nepicastat, and C. Strauss for helpful editing of the manuscript.
Funding
This work was supported by the National Institutes of Health (AG061175, NS102306, and DA038453 to DW; GM8602-22 to DL; MH116622 to RPT).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
DW is co-inventor on a patent concerning the use of selective dopamine β-hydroxylase inhibitors for the treatment of cocaine dependence (US-2010-0105748-A1; “Methods and Compositions for Treatment of Drug Addiction”). The other authors declare no conflicts of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Lustberg, D., Iannitelli, A.F., Tillage, R.P. et al. Central norepinephrine transmission is required for stress-induced repetitive behavior in two rodent models of obsessive-compulsive disorder. Psychopharmacology 237, 1973–1987 (2020). https://doi.org/10.1007/s00213-020-05512-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-020-05512-0